Patent Yard Sign in
Canadian application, no grantCanada

Process for the preparation of phenylalanine enamide derivatives

CA 2492441 A1 · Owner: Celltech R & D Limited · Inventors: Skead, Benjamin Mark; Brookes, Michael Handforth; Tyrrell, Nicholas David

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A process for the preparation of a class of phenylalanine enamide derivatives is described formula (1) wherein: Ar1 is an optionally substituted aromatic or heteroaromatic group; L2 is a linker group selected from -N(R4)- where R4 is a hydrogen atom or an optionally substituted straight or branched C1-6alkyl group, -CON(R4)-, or -S(O)2N(R4)-; R1 is a carboxylic acid (-CO2H) or a derivative or biostere thereof; R2 is a hydrogen atom or a C1-6alkyl group; Rx, Ry and Rz which may be the same or different is each an atom or group - L1(Alk1)n(R3)v; and the salts, solvates hydrates and N-oxides thereof; which , comprises reacting a compound of formula (2): wherein: Qa is a group -N(R4)H; …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 16, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 16, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 16, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 16, 2003
GrantedNo grant recorded
Term endedJuly 16, 2023
Patent numberCA 2492441 A1
Classification (IPC)C07D311/96 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedJuly 16, 2003Term endedJuly 16, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.